NSABP CO-7

NSABP CO-7

• 批准号: 7607580
• 负责人: Scott Henry Kurtzman
• 金额: $ 0.03万
• 依托单位: UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607580
• 关键词: Colon Carcinoma; Computer Retrieval of Information on Scientific Projects Database; Disease-Free Survival; Excision; Fluorouracil; Funding; Grant; Institution; Leucovorin; National Surgical Adjuvant Breast and Bowel Project; Patients; Relative (related person); Research; Research Personnel; Resources; Source; Staging; United States National Institutes of Health; oxaliplatin

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary aim of this study is to compare the relative efficacy of Fluorouracil (5-FU) + Leucovorin (LV) + Oxaliplatin (FLOX) with that of 5-FU + LV in prolonging disease-free survival among patients who have undergone a potentially curative resection of a stage II or III carcinoma of the colon. The secondary aim of the study is to compare the relative efficacy of FLOX with that of FL in prolonging Survival (S).

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究的主要目的是比较氟尿嘧啶（5-FU）+甲酰四氢叶酸（LV）+奥沙利铂（FLOX）与5-FU + LV在延长II期或III期结肠癌根治性切除患者无病生存期方面的相对疗效。 本研究的次要目的是比较FLOX与FL在延长生存期（S）方面的相对疗效。